Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Accounts Payables (2017 - 2021)

Cogent Biosciences has reported Accounts Payables over the past 5 years, most recently at $4.3 million for Q3 2021.

  • Quarterly results put Accounts Payables at $4.3 million for Q3 2021, up 580.59% from a year ago — trailing twelve months through Sep 2021 was $4.3 million (up 580.59% YoY), and the annual figure for FY2020 was $732000.0, down 77.0%.
  • Accounts Payables for Q3 2021 was $4.3 million at Cogent Biosciences, up from $2.0 million in the prior quarter.
  • Over the last five years, Accounts Payables for COGT hit a ceiling of $5.5 million in Q3 2018 and a floor of $315000.0 in Q1 2021.
  • Median Accounts Payables over the past 5 years was $1.6 million (2019), compared with a mean of $1.9 million.
  • Biggest five-year swings in Accounts Payables: tumbled 77.0% in 2020 and later surged 580.59% in 2021.
  • Cogent Biosciences' Accounts Payables stood at $1.3 million in 2017, then grew by 12.85% to $1.5 million in 2018, then surged by 109.55% to $3.2 million in 2019, then tumbled by 77.0% to $732000.0 in 2020, then skyrocketed by 494.13% to $4.3 million in 2021.
  • The last three reported values for Accounts Payables were $4.3 million (Q3 2021), $2.0 million (Q2 2021), and $315000.0 (Q1 2021) per Business Quant data.